No Detail Found!

Differences in gut microbiota and serum Trimethylamine N-oxide (TMAO) levels in patients with colorectal cancer with a small, nested case-control study

Author(s)
Jian Huang Department of Gastroenterology, The Eighth Affiliated Hospital, Sun Yat-sen University,Shenzhen, Guangdong 518033,China
Xiaohua Che Department of Gastroenterology, The Eighth Affiliated Hospital, Sun Yat-sen University,Shenzhen, Guangdong 518033,China
Qinglian Zhong Department of Gastroenterology, The Eighth Affiliated Hospital, Sun Yat-sen University,Shenzhen, Guangdong 518033,China
Abstract
The dysbiosis of the gut microbiota caused by drug metabolism and diets may influence the gastrointestinal (GI) barrier and their ability for normal attachment and further immunity system, which all could be associated with the medical efficacy of colorectal cancer (CRC) during chemotherapy. This study aims to investigate Trimethylamine N-oxide (TMAO), a gastrointestinal product readily entering the bloodstream, as a potential risk factor for various diseases, including CRC. To investigate the relationship between gut microbiota dysbiosis and carcinogenesis in CRC patients, we analyzed taxonomic alterations in the gut microbiota of 77 subjects, including 36 CRC patients and 41 normal controls. We collected samples of the participants' microbiome from their fecal material and utilized 16S rRNA sequencing to identify the microbial composition. Additionally, to predict the functions of the GI microbiota, Phylogenetic Investigation of Communities by Reconstructing Unobserved States (PICRUSt) was employed. This could serve as a promising biomarker for colorectal cancer. Moreover, the serum level of TMAO between the CRC and healthy controls was also compared, and it was observed that the intestinal microbiome was changed in CRC patients; however, the serum level of TMAO was not correlated with the progression of CRC. In conclusion, in the present study, instead of relying solely on TMAO, which is a convenient clinical test, we focused on the treatment of CRC by emphasizing the modification of the intestinal microbiome.
Publication Details
Page(s) 1-12
Published Journal: Asian Journal of Agriculture and Biology, Volume: 3, Issue: 0, Year: 2024

Request the full text from PASTIC

Keywords
16S rRNA, PICRUSt, CRC, Intestinal microbiome, TMAO
References
Abdellateif MS,Salem SE,Badr DM,Shaarawy S,Hussein MM,Zekri A-RN,Fouad MA .2020 .The prognostic significance of 5-fluorouracil induced inflammation and immuno-modulation in colorectal cancer patients. J. Inflamm. Res, 13 : 1245-1259.
Bae S,Ulrich CM,Neuhouser ML,Malysheva O,Bailey LB,Xiao L,Brown EC,Cushing-Haugen KL,Zheng Y,Cheng T-YD .2014 .Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study Cancer. Res, 74 : 7442-7452.
Brown JM,Hazen SL .2018 .Microbial modulation of cardiovascular disease. Nat. Rev. Microbiol, 16 : 171-181.
Castellarin M,Warren RL,Freeman JD,Dreolini L,Krzywinski M,Strauss J,Barnes R,Watson P,Allen-Vercoe E,Moore RA .2012 .Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res, 22 : 299-306.
Chang H,Mishra R,Cen C,Tang Y,Ma C,Wasti S,Wang Y,Ou Q,Chen K,Zhang J .2021 .Metagenomic analyses expand bacterial and functional profiling biomarkers for colorectal cancer in a Hainan cohort. China. Curr. Microbiol, 78 : 705-712.
Alexanderson Chen L,KA Chen L .2021 .Trajectories of sickness absence and disability pension before and after colorectal cancer: A Swedish longitudinal population-based matched cohort study. Plos One, 16 : e0245246.
Dohlman AB,Mendoza DA,Ding S,Gao M,Dressman H,Iliev ID,Lipkin SM,Shen X .2021 .The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissueresident microbiota from contaminants. Cell Host Microbe, 29 : 281-298.
Ekine-Afolabi BA,Njan AA,Rotimi SO,Ri A,Elbehi AM,Cash E,Adeyeye A,Govindarajulu M,Pinky PD,Steinke I,Bloemer J,Ramesh S,Kariharan T,Rella RT,Bhattacharya S,Dhanasekaran M,Suppiramaniam V .2020 .Gut metabolite TMAO induces synaptic plasticity deficits by promoting endoplasmic reticulum stress. Front. Mol. Neurosci, 13 : 138.
Guertin KA,Li XS,Graubard BI,Albanes D,Weinstein SJ,Goedert JJ,Wang Z,Hazen SL,Sinha R .2017 .Serum trimethylamine N-oxide, carnitine, choline, and betaine in relation to colorectal cancer risk in the alpha tocopherol, beta carotene cancer prevention study. Cancer Epidemiol. Biomarkers Prev, 26 : 945-952.
Guo J,Yu Z,Sun D,Zou Y,Liu Y,Huang L .2021 .Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma. Mol. Cancer, 20 : 10.
Jenq Hayase E,RR Hayase E .2020 .Too much TMAO and GVHD Blood. J. Am. Soc. Hematol, 136 : 383-385.
He Y,Timofeeva M,Zhang X,Xu W,Li X,Din FV,Svinti V,Farrington SM,Campbell H,Dunlop MG .2021 .Colorectal cancer risk variants rs10161980 and rs7495132 are associated with cancer survival outcome by a recessive mode of inheritance. Int. J. Cancer, 148 : 2774-2778.
Hozhabri H,Lashkari A,Razavi S-M and Mohammadian A .2021 .Integration of gene expression data identifies key genes and pathways in colorectal cancer. Med, 38 : 1-14.
Huang Q-Y F,Zhou C-R,Huang X-Y,Wang Q,Long H,Wu Q-M H .2020 .Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes. World J. Clin. Cases, 8 : 6213.
Janeiro MH,Ramírez MJ,Milagro FI,Martínez JA,Solas M .2018 .Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients, 10 : 1398.
Khan A,Nayeem SM .2020 .Effect of TMAO and Urea on Dimers and Tetramers of Amyloidogenic Heptapeptides (23FGAILSS29.) ACS Omega. , 5 : 26986-26998.
Lakshmi G,Yadav AK,Mehlawat N,Jalandra R,Solanki PR,Kumar A .2021 .Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor. Sci. Rep, 11 : 1338.
Leng Y,Chen Z,Ding H,Zhao X,Qin L,Pan Y .2021 .Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis. Cancer Cell Int, 21 : 1-19.
Li D,Lu Y,Yuan S,Cai X,He Y,Chen J,Wu Q,He D,Fang A,Bo Y,Song P,Bogaert D,Tsilidis K,Larsson SC,Yu H,Zhu H,Theodoratou E,Zhu Y,Li X .2022 .Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis. Am. J. Clin. Nutr, 116 : 230-243.
Liao H,Li C,Ai Y,Kou Y .2021 .Gut microbiome is more stable in males than in females during the development of colorectal cancer. J. Appl. Microbiol, 131 : 435-448.
Lin J,Huang Z,Lin X,Wu Q,Quan K,Cheng Y,Zheng M,Xu J,Dai Y,Qiu H .2020 .Rapid and label-free urine test based on surfaceenhanced Raman spectroscopy for the noninvasive detection of colorectal cancer at different stages. Biomed. Opt. Express, 11 : 7109-7119.
Liu N-N Q,Ge Y,Yi C-X L-Q,Tan J-C,Chu Q,Li J-Q,Wang H .2020 .Microbiome dysbiosis in lung cancer: from composition to therapy. NPJ Precis. Oncol, 4 : 33.
Liu X,Liu H,Yuan C,Zhang Y,Wang W,Hu S,Liu L,Wang Y .2017 .Preoperative serum TMAO level is a new prognostic marker for colorectal cancer. Biomark. Med, 11 : 443-447.
Luo C,Urgard E,Vooder T,Metspalu A .2011 .The role of COX-2 and Nrf2/ARE in antiinflammation and antioxidative stress: Aging and anti-aging. Med, 77 : 174-178.
Malla R .2020 .Microbiome conundrum in colon cancer: development, progression, and therapeutics. Crit. Rev. Oncog, 25(2) : 129-139.
Martins D,Mendes F,Schmitt F .2021 .Microbiome: a supportive or a leading actor in lung cancer?. Pathobiol, 88 : 198-207.
McMurdie PJ,Holmes S .2013 .Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PloS One, 8 : e61217.
Oellgaard J,Abitz WS,Schmidt HT,Rossing P,Johan von Scholten B .2017 .Trimethylamine Noxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer. Curr. Pharm. Des, 23 : 3699-3712.
Papandreou C,Moré M,Bellamine A .2020 .Trimethylamine N-oxide in relation to cardiometabolic health-cause or effect?. Nutrients, 12 : 1330.
Reddy BS,Narisawa T,Wright P,Vukusich D,Weisburger JH,Wynder EL .1975 .Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res, 35 : 287-290.
Restini CBA,Fink GD,Watts SW .2021 .Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved?. Pharmacol. Res, 163 : 105273.
Samerotte AL,Drazen JC,Brand GL,Seibel BA,Yancey PH .2007 .Correlation of trimethylamine oxide and habitat depth within and among species of teleost fish: an analysis of causation. Physiol. Biochem. Zool, 80 : 197-208.
Shi W,Shen L,Zou W,Wang J,Yang J,Wang Y,Liu B,Xie L,Zhu J,Zhang Z .2020 .The gut microbiome is associated with therapeutic responses and toxicities of neoadjuvant chemoradiotherapy in rectal cancer patients-a pilot study. Front. Cell. Infect. Microbiol, 10 : 562463.
Song M,Chan AT .2017 .Diet, gut microbiota, and colorectal cancer prevention: a review of potential mechanisms and promising targets for future research. Curr. Colorectal Cancer Rep, 13 : 429-439.
Kato Sun J,I Sun J .2016 .Gut microbiota, inflammation and colorectal cancer. Genes Dis, 3 : 130-143.
Wang Z,Bergeron N,Levison BS,Li XS,Chiu S,Jia X,Koeth RA,Li L,Wu Y,Tang WW .2019 .Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur. Heart J, 40 : 583-594.
Wirth U,Garzetti D,Jochum LM,Spriewald S,Kühn F,Ilmer M,Lee SM,Niess H,Bazhin AV,Andrassy J .2020 .Microbiome analysis from paired mucosal and fecal samples of a colorectal cancer biobank. Cancers, 12 : 3702.
Wong CC,Yu J .2023 .Gut microbiota in colorectal cancer development and therapy. Nat. Rev. Clin. Oncol, 10(7) : 429-452.
Wong SH,Yu J .2019 .Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol, 16 : 690-704.
Wu W-K S,Liu P-Y,Chen C-C H-L,Chuang H-L,Chen Y-H,Zou H-B Kuo H-C and Kuo C-H .2020 .Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery. Microbiome, 8 : 1-17.
Xu R,Wang Q,Li L .2015 .A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics, 16 : 1-9.
Yang S,Dai H,Lu Y,Li R,Gao C,Pan S .2022 .Trimethylamine N-Oxide promotes cell proliferation and angiogenesis in colorectal cancer. J. Immunol. Res, 7043856 : .
Yi Y,Shen L,Shi W,Xia F,Zhang H,Wang Y,Zhang J,Wang Y,Sun X,Zhang Z .2021 .Gut microbiome components predict response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a prospective, longitudinal study. Clin. Cancer Res, 27 : 1329-1340.
Zhang H,Chang Y,Zheng Q,Zhang R,Hu C,Jia W .2019 .Altered intestinal microbiota associated with colorectal cancer. Front. Med, 13 : 461-470.
Zhang M,Zhou H,Xu S,Liu D,Cheng Y,Gao B,Li X,Chen J .2020 .The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy. Ann. Palliat. Med, 9 : 4211-4227.
Zheng L,Xu J,Sai B,Zhu Y,Wang L,Yin N,Yu F,Zhou W,Wu M,Tang J .2020 .Microbiome related cytotoxically active CD8+ TIL are inversely associated with lung cancer development. Front. Oncol, 10 : 531131.
Zhou Z,Ge S,Li Y,Ma W,Liu Y,Hu S,Zhang R,Ma Y,Du K,Syed A .2020 .Human gut microbiome-based knowledgebase as a biomarker screening tool to improve the predicted probability for colorectal cancer. Front. Microbiol, 11 : 596027.
0

Citations

0

Downloads

17

Views